Quick10K

⚲

Hillman Companies

Filings

10-Q	2020-09-26	Filed 2020-10-26
10-Q	2020-06-27	Filed 2020-08-06
10-Q	2020-03-28	Filed 2020-05-11
10-K	2019-12-28	Filed 2020-03-27
10-Q	2019-09-28	Filed 2019-11-12
10-Q	2019-06-29	Filed 2019-08-12
10-Q	2019-03-30	Filed 2019-05-13
10-K	2018-12-29	Filed 2019-03-28
10-Q	2018-09-29	Filed 2018-11-09
10-Q	2018-06-30	Filed 2018-08-08
10-Q	2018-03-31	Filed 2018-05-15
10-K	2017-12-30	Filed 2018-03-21
10-Q	2017-09-30	Filed 2017-11-13
10-Q	2017-07-01	Filed 2017-08-11
10-Q	2017-04-01	Filed 2017-05-12
10-K	2016-12-31	Filed 2017-03-30
10-Q	2016-09-30	Filed 2016-11-14
10-Q	2016-06-30	Filed 2016-08-15
10-Q	2016-03-31	Filed 2016-05-16
10-K	2015-12-31	Filed 2016-03-28
10-Q	2015-09-30	Filed 2015-11-16
10-Q	2015-06-30	Filed 2015-08-14
10-Q	2015-03-31	Filed 2015-05-15
10-K	2014-12-31	Filed 2015-03-27
10-Q	2014-09-30	Filed 2014-11-14
10-Q	2014-06-30	Filed 2014-08-14
10-Q	2014-03-31	Filed 2014-05-13
10-K	2013-12-31	Filed 2014-03-28
10-Q	2013-09-30	Filed 2013-11-14
10-Q	2013-06-30	Filed 2013-08-14
10-Q	2013-03-31	Filed 2013-05-15
10-K	2012-12-31	Filed 2013-03-29
10-Q	2012-09-30	Filed 2012-11-14
10-Q	2012-06-30	Filed 2012-08-14
10-Q	2012-03-31	Filed 2012-05-15
10-K	2011-12-31	Filed 2012-03-26
10-Q	2011-09-30	Filed 2011-11-14
10-Q	2011-06-30	Filed 2011-08-15
10-Q	2011-03-31	Filed 2011-05-13
10-K	2010-12-31	Filed 2011-03-31
10-Q	2010-09-30	Filed 2010-11-15
10-Q	2010-06-30	Filed 2010-08-16
10-Q	2010-03-31	Filed 2010-05-10
10-K	2009-12-31	Filed 2010-03-26

Reports

8-K	2020-07-20
8-K	2019-11-15
8-K	2019-11-07
8-K	2019-09-13
8-K	2019-07-30
8-K	2019-07-25
8-K	2019-06-27
8-K	2019-05-02
8-K	2019-03-20
8-K	2018-10-01
8-K	2018-09-04
8-K	2018-08-28
8-K	2018-05-31
8-K	2018-05-02
8-K	2018-04-16

Hillman Companies Financials

HLM Metrics, Comps, Filings

Quarterly | Annual

Valuation ($BB)

Market Cap, Enterprise Value

Balance Sheet ($BB)

Assets, Equity

Income Statement ($BB Quarterly)

Revenue, G Profit, Net Income

Cash Flow ($BB Quarterly)

Ops, Inv, Fin


Comps ($MM TTM)	Market Cap	Gross Margin	EV/EBITDA	Ret on Assets	Assets	Liabilities	Revenue	G Profit	Net Income	EBITDA	EV
20 20 Global (TWGL)
024 Pharma (EEIG)
111 (YI)				0%	1,546	323	0	0	0	0	-854
1 800 Flowers Com (FLWS)	944	42%	13.3	6%	665	336	1,266	534	37	75	1,001
10x Genomics (TXG)	4,805	75%	-490.3	-2%	573	151	61	46	-10	-9	4,357
12 Retech (RETC)	0	32%	-0.1	-1,385%	1	20	1	0	-15	-15	1
11 Good Energy (ELVN)
1347 Property Insurance Holdings (PIH)	34	0%	0.4	-5%	164	108	18	0	-8	-8	-3
1347 Capital Corp (TFSC)
180 Degree Capital (TURN)
1847 Holdings (EFSH)		25%	-2.4	-15%	19	23	27	7	-3	-1	3
1895 Bancorp of Wisconsin (BCOW)	46,153		12,508.1	-0%	441	383	0	0	-0	4	46,142
1st Constitution Bancorp (FCCY)	165	0%	4.4	1%	1,343	1,204	0	0	14	33	144
1st Franklin Financial (FFC)	4		-0.6	7%	905	645	0	0	62	80	-46
24 7 Kid Doc (TVMD)
1st Source (SRCE)	1,200		7.9	1%	6,691	5,858	0	0	70	136	1,073
2050 Motors (ETFM)	0		-0.2	-166,272,400%	0	2	0	0	-2	-2	0
21Vianet Group (VNET)	6,005			0%	11,151	5,788	0	0	0	0	3,344
22nd Century (XXII)	302	1%	-14.1	-36%	62	7	26	0	-22	-21	302
1Life Healthcare (ONEM)


Balance Sheet ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-04-01	2017-07-01	2017-09-30	2017-12-30	2018-03-31	2018-06-30	2018-09-29	2018-12-29	2019-03-30	2019-06-29	2019-09-28
Cash	3	14	12	8	10	5	66	23	21	26	35	27				2	8	9	11	10	16	5	14	2	12	24	10	5	11	8	28	15	17	13
Accounts Receivable	74	72	64	72	80	81	62	93	104	106	88	94				108	121	112	74	84	89	82	71	78	86	85	79	85	95	94	111	113	125	116
Inventory	103	99	104	106	116	119	114	171	172	180	178	182				228	256	253	244	239	230	231	221	233	230	224	219	240	248	269	320	315	325	333
PP&E	69	67	66	66	65	67	113	84	86	93	157	95				112	112	110	153	109	111	116	194	121	129	132	252	165	173	205	339	209	203	203
Assets	1,125	1,125	1,128	1,129	1,140	1,136	1,176	1,262	1,267	1,283	1,265	1,254				1,910	1,945	1,920	1,864	1,831	1,825	1,800	1,782	1,784	1,798	1,800	1,799	1,814	1,836	2,010	2,431	2,468	2,465	2,480
Accounts Payable	30	29	31	34	41	33	33	48	50	48	44	47				77	95	77	65	59	73	71	62	75	79	73	74	101	117	116	135	125	143	141
Long-Term Debt	0	0	0	0	0	0	0	0	0		650								900			974	975	977	972	971	990	1,004	1,026	1,205	1,606	1,586	1,592	1,594
Liabilities	830	829	837	839	850	844	891	981	985	998	986	983				1,417	1,457	1,438	1,396	1,363	1,355	1,332	1,324	1,330	1,339	1,337	1,272	1,308	1,346	1,529	1,992	2,061	2,074	2,104
Stockholders' Equity	283	284	279	277	548	617	270	336	351	352	356	358				492	488	482	469	467	469	468	458	454	459	463	527	507	490	481	439		390	376


Income Statement ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-04-01	2017-07-01	2017-09-30	2017-12-30	2018-03-31	2018-06-30	2018-09-29	2018-12-29	2019-03-30	2019-06-29	2019-09-28
Revenue		138		128	147	414	132	144	193	192	173	155			181	181			179		227	212	187	189	224	219	206	208	246	244	277	288	325	317
Cost of Revenue																													134	130		166
Gross Profit																													112	114		122
R&D
SG&A		41		45	51	51		48	60	59	219	56									67	68		67	67	69	71	71	79	84		92	97	99
Tax		0		-2	1	0		0	1	7	-4	0								5	2	0		0	2	0	-80	3	1	0		5	-3	-4
Net Income		1	-5	-3	6	4	-7	3	10	15	-3	2			-5	-10	-9	-0	-9	-8	2	-0	-8	-7	1	-1	65	-10	-14	-11	-35	-35	-19	-15


Cash Flow ($MM)	2011-06-30	2011-09-30	2011-12-31	2012-03-31	2012-06-30	2012-09-30	2012-12-31	2013-03-31	2013-06-30	2013-09-30	2013-12-31	2014-03-31	2014-06-30	2014-09-30	2014-12-31	2015-03-31	2015-06-30	2015-09-30	2015-12-31	2016-03-31	2016-06-30	2016-09-30	2016-12-31	2017-04-01	2017-07-01	2017-09-30	2017-12-30	2018-03-31	2018-06-30	2018-09-29	2018-12-29	2019-03-30	2019-06-29	2019-09-28
Cash Operating				0	3	-4		16	1	-1	42	3										19		-5	33	25		2	13	-10		-2	27	10
Cash Investing				-5	-5	-7		0	-0	0	-103	0										-12		-10	-16	-11		-21	-19	-169		-10	-10	-17
Cash Financing				1	4	-8		74	-1	-1	-71	0										-17		3	-6	-1		14	11	176		-1	-15	3